AKT1 and diabetic retinopathy: Lu et al. found that miR-21 inhibition can down-regulate the activity of PI3K/Akt/VEGF pathway dependent on PTEN in diabetic retinopathy, and inhibit the growth and angiogenesis of retinal vascular endothelial cells [29].